Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imaging Biomarkers of Myofascial Pain
NCT07322445Phase 2Recruiting
- Sponsor
- Washington University School of Medicine
- Start
- Oct 2023
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
A Phase 2 trial of Lidocaine Hydrochloride Injection, without epinephrine, bupivacaine hydrochloride 0.75% injection in myofascial pain syndrome (MPS), sponsored by Washington University School of Medicine. Started Oct 2023; status: recruiting.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrinebupivacaine hydrochloride 0.75% injection
03
Conditions
myofascial pain syndrome (MPS)
Beyond the preview
Go deeper on NCT07322445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07322445.